Cancellations and suspensions

This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.

Find out more about Cancellations and Suspensions.

1820 result(s) found, displaying 276 to 300

NOUMED RANITIDINE ranitidine (as hydrochloride) 150 mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

17 June 2023

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17-06-2023
NOUMED RANITIDINE ranitidine (as hydrochloride) 300 mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

17 June 2023

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17-06-2023
RANI 2 ranitidine 150mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

17 June 2023

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17-06-2023
RANI 2 ranitidine 150mg (as hydrochloride) tablet bottle (Suspension from the ARTG under s.29D(1)(b))

17 June 2023

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17-06-2023
RANI 2 ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

17 June 2023

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17-06-2023
RANI 2 ranitidine 300mg (as hydrochloride) tablet bottle (Suspension from the ARTG under s.29D(1)(b))

17 June 2023

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17-06-2023
S.T.A.R, Mobile-bearing total ankle prosthesis (Cancellation from the ARTG under subsection 41GN(1) of the Act)

13 June 2023

Cancellation or suspension

Regulatory action due to As the sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a)., effective 5 June 2023
Mask, Surgical, Single-use' (Cancellation from the ARTG under subsection 41GN(1) of the Act.)

9 June 2023

Cancellation or suspension

Regulatory action due to Failure to comply with a condition of inclusion, effective 09-06-2023
Mask, <specify> (Cancellation from the ARTG under section 9F(2) of the Act)

26 May 2023

Cancellation or suspension

Regulatory action due to Removal of goods are not therapeutic goods., effective 26-05-2023
AU D00226, AU D00380, AU D00471, AU D00657, AU D00736 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 03/05/2022
AU D00853 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 06/10/2022
AU D00884 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 17/03/2023
AU Q00121 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 06/10/2022
AU Q00133, AU D00135 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 24/03/2023
AU Q00135, AU D00151, AU D00317, AU D00475 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 06/10/2022
AU Q00162, AU D00165, AU D00269, AU D00276, AU D00867 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989.)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 13/04/2023
AU Q00173 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 28/02/2023
AU Q00254, AU D00249, AU D00286 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 17/03/2023
AU Q00365, AU D00441, AU D00711 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 07/11/2022
AU Q00419, AU D00631 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 17/03/2023
AU Q00462, AU D00804 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

23 May 2023

Cancellation or suspension

Regulatory action due to Voluntary revocation at the request of the manufacturer, effective 07/11/2022
Convection blood/fluid warmer high-flow (Cancelled from the ARTG under subsection 41GK of the Act)

4 May 2023

Cancellation or suspension

Regulatory action due to The suspension of the Device from the ARTG was not revoked before the expiry date of the suspension.
Convection blood/fluid warmer high-flow (Cancelled from the ARTG under subsection 41GK of the Act)

4 May 2023

Cancellation or suspension

Regulatory action due to The suspension of the Device from the ARTG was not revoked before the expiry date of the suspension.
Royal Mom (Cancelled from the ARTG under 30(1C) of the Act)

18 April 2023

Cancellation or suspension

Regulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31.
Royal Mom (Cancelled from the ARTG under 30(1C) of the Act)

18 April 2023

Cancellation or suspension

Regulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31.

Sub menu

Cancellations and suspensions

Filter results

Action

Date of effect

NOUMED RANITIDINE ranitidine (as hydrochloride) 150 mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

NOUMED RANITIDINE ranitidine (as hydrochloride) 300 mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

RANI 2 ranitidine 150mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

RANI 2 ranitidine 150mg (as hydrochloride) tablet bottle (Suspension from the ARTG under s.29D(1)(b))

RANI 2 ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))

RANI 2 ranitidine 300mg (as hydrochloride) tablet bottle (Suspension from the ARTG under s.29D(1)(b))

S.T.A.R, Mobile-bearing total ankle prosthesis (Cancellation from the ARTG under subsection 41GN(1) of the Act)

Mask, Surgical, Single-use' (Cancellation from the ARTG under subsection 41GN(1) of the Act.)

Mask, <specify> (Cancellation from the ARTG under section 9F(2) of the Act)

AU D00226, AU D00380, AU D00471, AU D00657, AU D00736 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU D00853 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU D00884 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00121 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00133, AU D00135 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00135, AU D00151, AU D00317, AU D00475 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00162, AU D00165, AU D00269, AU D00276, AU D00867 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989.)

AU Q00173 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00254, AU D00249, AU D00286 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00365, AU D00441, AU D00711 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00419, AU D00631 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

AU Q00462, AU D00804 (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989)

Convection blood/fluid warmer high-flow (Cancelled from the ARTG under subsection 41GK of the Act)

Convection blood/fluid warmer high-flow (Cancelled from the ARTG under subsection 41GK of the Act)

Royal Mom (Cancelled from the ARTG under 30(1C) of the Act)

Royal Mom (Cancelled from the ARTG under 30(1C) of the Act)

Help us improve the Therapeutic Goods Administration site

Site notifications

Cancellations and suspensions

Filter results

Action

Date of effect

Help us improve the Therapeutic Goods Administration site